drugset / Trial / NCT04589819
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
Phase 4
Enrolling by invitation
183 enrolled
University of South Carolina
Eisenhower Army Medical Center · collabMoncrief Army Health Clinic · collabUnited States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The project goals are to improve combat readiness of U.S. Soldiers and sustain the availability of the military to deploy by, 1) decreasing the number of days not physically ready for duty after diagnosis of a diaphyseal tibial stress fracture, 2) decreasing the need for a physical profile or medical discharge board after bone stress injury, and 3) decreasing the recurrence rates of bone stress injuries.
Timeline
- Start
- 2022-12-08
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Teriparatide | Protein / enzyme biologic | 20 mg | — |
Indications
No indication recorded.